Ranking Profile - Nabriva Therapeutics Plc

Introduction

Nabriva Therapeutics Plc (Nabriva) is a biopharmaceutical company that researches and develops antibiotics for the treatment of infections. The company offers product candidates such as Xenleta (lefamulin), CONTEPO (fosfomycin), being developed in both intravenous and oral formulations for the treatment of community-acquired bacterial pneumonia. Its other pipeline products comprise BC-7013 for the topical treatment of a variety of gram-positive infections including uncomplicated skin and skin structure infections and Contepo to treat urinary tract infections. It partners with pharmaceutical and biotechnology companies. It has an operational presence in Austria and the US. Nabriva is headquartered in Dublin, Ireland.